Advanced Search
Contact | Corporate | Help

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Sponsors:
  • GlaxoSmithKline
Phases:
  • Phase II
IndicationsAcronym:
  • Allergic Rhinitis
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: SB-705498
  • Drug: FP
  • Drug: placebo
Enrollment:
70

Additional information about NCT01424397.


SourceSolution © 2008-2012